The global demand for Neurostimulation Devices Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028. Whereas with regards to volume, the market was calculated XX Kilo Units in 2021 and foreseen to touch XX Kilo Units by 2028 with a CAGR of XX% during 2022-2028.
Neurostimulation is a process that can be defined as the alteration of neural activity for therapies using implanted medical devices. Various devices are used for neurostimulation known as neurostimulation devices or neurostimulators. They are very helpful in the treatment of neurological diseases. They are widely used for the treatment of Perkinson's disease, various chronic disorders and epilepsy, and even for depression. Different movement disorders also use neurostimulation devices for treatment in patients.
Market Dynamics
The major boost for the market is in the form of increasing the geriatric population and the rising investment behind the development of advanced techniques and therapies for the treatment of chronic problems. Chronic diseases mostly do not have any definite treatment and this technology is helping to close that gap. The COVID-19 outbreak has also caused a growth in the market as there has been an increase in co-morbid diseases like epilepsy and migraine that can be effectively treated using neurostimulator devices. The increasing number of neurological diseases is boosting the growth of the neurostimulator devices market. The only major challenge faced by the market is the high cost of production of such devices and most of the hospitals are not advanced enough to incorporate such advanced techniques in their operational procedures. This is the only restraint being faced by the market for neurostimulator devices.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of neurostimulation devices.
Market Segmentation
The entire neurostimulation devices market has been sub-categorized into product and application. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Product
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Sacral Nerve Stimulators
- Vagus Nerve Stimulators
- Gastric Electric Stimulators
By Application
- Pain Management
- Epilepsy
- Essential Tremor
- Urinary and Fecal Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson's Disease
- Others
Regional Analysis
This section covers regional segmentation which accentuates on current and future demand for neurostimulation devices market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Neurostimulation Devices Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the neurostimulation devices market include Abbott Laboratories, Aleva neurotherapeutics SA, Boston scientific corporation, ElectroCore Inc., EndoStim Inc., Medtronic plc, NeuroPace Inc., Nevro Corporation, Neuronetics Inc., NeuroSigma, Inc., Synapse Biomedical Inc. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.